Volcano Corp., Stanford University, Cardialysis and the Cardiovascular Research Foundation in which Volcano will provide ...
The FDA will convene a Medical Device Dispute Resolution Panel (MDDRP) on Dec. 15 to consider the first device to ...
The Laboratory Services unit of Rheologics has launched a Whole Blood Viscosity (WBV) testing program for physicians ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
Cardiac Science has begun shipping its news Powerheart G3 Plus, a CPR-enhanced addition to the Powerheart automated ...
A strong grassroots effort among physicians played a key role in staving off a Medicare physician payment cut that would ...
The FDA panel that convened for an intense, two-day review of drug-eluting stents last week heard key testimony from ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
Phase III of CoreValve’s international trial for its patented 18-French Revalving System is now one-third enrolled since ...
FUJIFLM Medical Systems USA, Inc. (“Fuji”) and Problem Solving Concepts, Inc. (“ProSolv”) have announced a co-marketing ...
Agfa HealthCare has signed a contract with the National Heart Centre (NHC) of Singapore, the national referral centre ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
The FDA panel that is re-evaluating the safety of drug-eluting stents convenes Dec. 7 and 8 at the Hilton Washington DC ...
Taking anti-platelet medication longer than current recommendations may lower heart attack or death risks for patients ...
The American Heart Association has published a report demonstrating that adolescent boys have a significantly increased ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
The FDA was notified on Dec. 2 that Pfizer will suspend a large, Phase 3 trial evaluating the investigational ...
The FDA will revisit a device tomorrow that it cleared for U.S. sale three years ago — drug-eluting stents will be the ...
The Society for Cardiac Angiography and Interventions (SCAI) has extended the abstract deadline for its 30th Annual ...
December 12, 2006
